Undetermined stroke with an embolic pattern—a common phenotype with high early recurrence risk

References

• Hart RG, Diener HC, Coutts SB, Easton JD, Granger CB, O’Donnell MJ, et al. Embolic strokes of undetermined source: the case for a new clinical construct. Lancet Neurol. 2014;1:429–38.
   Google Scholar
• Sacco RL, Prabhakaran S, Thompson JL, Murphy A, Sciacca RR, Levin B, et al. Comparison of warfarin versus aspirin for the prevention of recurrent stroke or death: subgroup analyses from the Warfarin-Aspirin Recurrent Stroke Study. Cerebrovasc Dis. 2006;2:4–12.
   Web of Science ®Google Scholar
• Palomeras Soler E, Fossas Felip P, Cano Orgaz AT, Sanz Cartagena P. Cryptogenic infarct. A follow-up period of 1 year study. Neurologia. 2009;24:304–8.
   PubMed Web of Science ®Google Scholar
• Soda T, Nakayasu H, Maeda M, Kusumi M, Kowa H, Awaki E, et al. Stroke recurrence within the first year following cerebral infarction—Tottori University Lacunar Infarction Prognosis Study (TULIPS). Acta Neurol Scand. 2004;110:343–9.
   PubMed Web of Science ®Google Scholar
• Mas JL, Arquizan C, Lamy C, Zuber M, Cabanes L, Derumeaux G, et al. Recurrent cerebrovascular events associated with patent foramen ovale, atrial septal aneurysm, or both. N Engl J Med. 2001;345:1740–6.
   PubMed Web of Science ®Google Scholar
• Putaala J, Haapaniemi E, Metso AJ, Metso TM, Artto V, Kaste M, et al. Recurrent ischemic events in young adults after first-ever ischemic stroke. Ann Neurol. 2010;68:661–71.
   PubMed Web of Science ®Google Scholar
• Furlan AJ, Reisman M, Massaro J, Mauri L, Adams H, Albers GW, et al. Closure or medical therapy for cryptogenic stroke with patent foramen ovale. N Engl J Med. 2012;366:991–9.
   PubMed Web of Science ®Google Scholar
• Homma S, DiTullio MR, Sacco RL, Sciacca RR, Mohr JP; PICSS Investigators. Age as a determinant of adverse events in medically treated cryptogenic stroke patients with patent foramen ovale. Stroke. 2004;3:2145–9.
   Web of Science ®Google Scholar
• Arauz A, Murillo L, Marquez JM, Tamayo A, Cantu C, Roldan FJ, et al. Long-term risk of recurrent stroke in young cryptogenic stroke patients with and without patent foramen ovale. Int J Stroke. 2012;7:631–4.
   PubMed Web of Science ®Google Scholar
• Almekhlafi MA, Wilton SB, Rabi DM, Ghali WA, Lorenzetti DL, Hill MD. Recurrent cerebral ischemia in medically treated patent foramen ovale: a meta-analysis. Neurology. 2009;73:89–97.
   PubMed Web of Science ®Google Scholar
• De Castro S, Cartoni D, Fiorelli M, Rasura M, Anzini A, Zanette EM, et al. Morphological and functional characteristics of patent foramen ovale and their embolic implications. Stroke. 2000;31:2407–13.
   PubMed Web of Science ®Google Scholar
• Vallejos J, Jaramillo A, Reyes A, Illanes S, Orellana P, Manterola J, et al. Prognosis of cryptogenic ischemic stroke: a prospective single-center study in Chile. J Stroke Cerebrovasc Dis. 2012;21:621–8.
   PubMed Web of Science ®Google Scholar
• Weber R, Goertler M, Benemann J, Diener HC, Weimar C;German Stroke Study Collaboration. Prognosis after cryptogenic cerebral ischemia in patients with coagulopathies. Cerebrovasc Dis. 2009;28:611–17.
   PubMed Web of Science ®Google Scholar
• Petty GW, Brown RD Jr, Whisnant JP, Sicks JD, O’Fallon WM, Wiebers DO. Ischemic stroke subtypes: a population-based study of functional outcome, survival, and recurrence. Stroke. 2000;31:1062–8.
   PubMed Web of Science ®Google Scholar
• Kolominsky-Rabas PL, Weber M, Gefeller O, Neundoerfer B, Heuschmann PU. Epidemiology of ischemic stroke subtypes according to TOAST criteria: incidence, recurrence, and long-term survival in ischemic stroke subtypes: a population-based study. Stroke. 2001;32:2735–40.
   PubMed Web of Science ®Google Scholar
• Gladstone DJ, Spring M, Dorian P, Panzov V, Thorpe KE, Hall J, et al. Atrial fibrillation in patients with cryptogenic stroke. N Engl J Med. 2014;370:2467–77.
   PubMed Web of Science ®Google Scholar
• Sanna T, Diener HC, Passman RS, Di Lazzaro V, Bernstein RA, Morillo CA, et al. Cryptogenic stroke and underlying atrial fibrillation. N Engl J Med. 2014;370:2478–86.
   PubMed Web of Science ®Google Scholar
• Ntaios G, Papavasileiou V, Milionis H, Makaritsis K, Manios E, Spengos K, et al. Embolic strokes of undetermined source in the athens stroke registry: a descriptive analysis. Stroke. 2015;46:176–81.
   PubMed Web of Science ®Google Scholar
• Lip GY, Nieuwlaat R, Pisters R, Lane DA, Crijns HJ. Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the euro heart survey on atrial fibrillation. Chest. 2010;137: 263–72.
   PubMed Web of Science ®Google Scholar
• Adams HP Jr, Bendixen BH, Kappelle LJ, Biller J, Love BB, Gordon DL, et al. Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment. Stroke. 1993;24:35–41.
   PubMed Web of Science ®Google Scholar
• Ay H, Furie KL, Singhal A, Smith WS, Sorensen AG, Koroshetz WJ. An evidence-based causative classification system for acute ischemic stroke. Ann Neurol. 2005;58:688–97.
   PubMed Web of Science ®Google Scholar
• Mitchell LB, Southern DA, Galbraith D, Ghali WA, Knudtson M, Wilton SB, et al. Prediction of stroke or TIA in patients without atrial fibrillation using CHADS2 and CHA2DS2-VASc scores. Heart. 2014;100:1524–30.
   PubMed Web of Science ®Google Scholar
• Ntaios G, Vemmou A, Koroboki E, Savvari P, Makaritsis K, Saliaris M, et al. The type of atrial fibrillation is associated with long-term outcome in patients with acute ischemic stroke. Int J Cardiol. 2013;167: 1519–23.
   PubMed Web of Science ®Google Scholar
• Bang OY, Lee PH, Joo SY, Lee JS, Joo IS, Huh K. Frequency and mechanisms of stroke recurrence after cryptogenic stroke. Ann Neurol. 2003;54:227–34.
   PubMed Web of Science ®Google Scholar
• Mohr JP, Thompson JL, Lazar RM, Levin B, Sacco RL, Furie KL, et al. A comparison of warfarin and aspirin for the prevention of recurrent ischemic stroke. N Engl J Med. 2001;345:1444–51.
   PubMed Web of Science ®Google Scholar
• Grau AJ, Weimar C, Buggle F, Heinrich A, Goertler M, Neumaier S, et al. Risk factors, outcome, and treatment in subtypes of ischemic stroke: the German stroke data bank. Stroke. 2001;32:2559–66.
   PubMed Web of Science ®Google Scholar
• Bang OY, Ovbiagele B, Kim JS. Evaluation of cryptogenic stroke with advanced diagnostic techniques. Stroke. 2014;45:1186–94.
   PubMed Web of Science ®Google Scholar
• Pajunen P, Koukkunen H, Ketonen M, Jerkkola T, Immonen-Raiha P, Karja-Koskenkari P, et al. The validity of the Finnish Hospital Discharge Register and Causes of Death Register data on coronary heart disease. Eur J Cardiovasc Prev Rehabil. 2005;12:132–7.
   PubMed Web of Science ®Google Scholar
• Beigel R, Wunderlich NC, Ho SY, Arsanjani R, Siegel RJ. The left atrial appendage: anatomy, function, and noninvasive evaluation. JACC Cardiovasc Imaging. 2014;7:1251–65.
   PubMed Web of Science ®Google Scholar